Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysis.

Wang F, Qin Z, Si S, Tang J, Xu L, Xu H, Li R, Han P, Yang H.

Oncotarget. 2017 Jul 5;8(34):57440-57450. doi: 10.18632/oncotarget.19023. eCollection 2017 Aug 22.

2.

Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.

Stepp MW, Doll MA, Samuelson DJ, Sanders MA, States JC, Hein DW.

BMC Cancer. 2017 Mar 31;17(1):233. doi: 10.1186/s12885-017-3221-9.

3.

Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine N-acetyltransferase 1.

Carlisle SM, Trainor PJ, Yin X, Doll MA, Stepp MW, States JC, Zhang X, Hein DW.

Metabolomics. 2016 Jul;12(7). pii: 111. Epub 2016 Jun 21.

4.

Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.

Wang X, Yang S, Gu J, Deng J.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7505-7508. Print 2016 Dec.

5.
6.

NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity.

Adithan C, Subathra A.

Indian J Med Res. 2016 May;143(5):542-4. doi: 10.4103/0971-5916.187101. No abstract available.

7.

A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy.

Cordes H, Thiel C, Aschmann HE, Baier V, Blank LM, Kuepfer L.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):6134-45. doi: 10.1128/AAC.00508-16. Print 2016 Oct.

8.

Single-Ascending-Dose Pharmacokinetic Study of Tribendimidine in Opisthorchis viverrini-Infected Patients.

Duthaler U, Sayasone S, Vanobbergen F, Penny MA, Odermatt P, Huwyler J, Keiser J.

Antimicrob Agents Chemother. 2016 Sep 23;60(10):5705-15. doi: 10.1128/AAC.00992-16. Print 2016 Oct.

9.

Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.

Matthis AL, Zhang B, Denson LA, Yacyshyn BR, Aihara E, Montrose MH.

Inflamm Bowel Dis. 2016 Aug;22(8):1793-802. doi: 10.1097/MIB.0000000000000823.

10.

Evidence for extensive pleiotropy among pharmacogenes.

Oetjens MT, Bush WS, Denny JC, Birdwell K, Kodaman N, Verma A, Dilks HH, Pendergrass SA, Ritchie MD, Crawford DC.

Pharmacogenomics. 2016 Jun;17(8):853-66. doi: 10.2217/pgs-2015-0007. Epub 2016 Jun 1.

11.

Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study.

van Waateringe RP, Slagter SN, van der Klauw MM, van Vliet-Ostaptchouk JV, Graaff R, Paterson AD, Lutgers HL, Wolffenbuttel BH.

Eur J Clin Invest. 2016 May;46(5):481-90. doi: 10.1111/eci.12627. Epub 2016 Apr 15.

12.

Risk of Lung Cancer in Workers Exposed to Benzidine and/or Beta-Naphthylamine: A Systematic Review and Meta-Analysis.

Tomioka K, Saeki K, Obayashi K, Kurumatani N.

J Epidemiol. 2016 Sep 5;26(9):447-58. doi: 10.2188/jea.JE20150233. Epub 2016 Mar 5. Review.

13.

N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.

Yucesoy B, Kissling GE, Johnson VJ, Lummus ZL, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

J Occup Environ Med. 2015 Dec;57(12):1331-6. doi: 10.1097/JOM.0000000000000561.

14.

Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.

Maggo SD, Savage RL, Kennedy MA.

Clin Pharmacokinet. 2016 Apr;55(4):419-36. doi: 10.1007/s40262-015-0324-9. Review. Erratum in: Clin Pharmacokinet. 2016 Apr;55(4):437.

15.

Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.

Stepp MW, Mamaliga G, Doll MA, States JC, Hein DW.

Biochem Biophys Rep. 2015 Sep;3:45-50.

16.

Caffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.

Eny KM, Orchard TJ, Miller RG, Maynard J, Grant DM, Costacou T, Cleary PA, Braffett BH, Paterson AD; DCCT/EDIC Research Group.

Diabetes Technol Ther. 2015 Oct;17(10):726-34. doi: 10.1089/dia.2015.0017. Epub 2015 Jul 20.

17.

Gene-by-Environment Interactions in Pancreatic Cancer: Implications for Prevention.

Jansen RJ, Tan XL, Petersen GM.

Yale J Biol Med. 2015 Jun 1;88(2):115-26. eCollection 2015 Jun. Review.

18.
19.

Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene.

Knowles JW, Xie W, Zhang Z, Chennamsetty I, Assimes TL, Paananen J, Hansson O, Pankow J, Goodarzi MO, Carcamo-Orive I, Morris AP, Chen YD, Mäkinen VP, Ganna A, Mahajan A, Guo X, Abbasi F, Greenawalt DM, Lum P, Molony C, Lind L, Lindgren C, Raffel LJ, Tsao PS; RISC (Relationship between Insulin Sensitivity and Cardiovascular Disease) Consortium; EUGENE2 (European Network on Functional Genomics of Type 2 Diabetes) Study; GUARDIAN (Genetics UndeRlying DIAbetes in HispaNics) Consortium; SAPPHIRe (Stanford Asian and Pacific Program for Hypertension and Insulin Resistance) Study, Schadt EE, Rotter JI, Sinaiko A, Reaven G, Yang X, Hsiung CA, Groop L, Cordell HJ, Laakso M, Hao K, Ingelsson E, Frayling TM, Weedon MN, Walker M, Quertermous T.

J Clin Invest. 2015 Apr;125(4):1739-51. doi: 10.1172/JCI74692. Epub 2015 Mar 23. Erratum in: J Clin Invest. 2016 Jan;126(1):403. Chennemsetty, Indumathi [corrected to Chennamsetty, Indumathi].

20.

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.

Tiang JM, Butcher NJ, Minchin RF.

Cancer Med. 2015 Apr;4(4):565-74. doi: 10.1002/cam4.415. Epub 2015 Jan 28.

Supplemental Content

Support Center